Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (2720)	10/22/2000 7:39:58 PM
From: Eric Fader	Respond to of 5582

Zicam shortens the duration of colds. Zicam prevents colds. Zicam has nothing to do with other companies' zinc products. Zicam is blowing out of stores that carry it and advertising has just started. Zicam is early in its product life and GumTech has international sales to look forward to. Zicam is well on its way to achieving "household name" status. Most consumers who are buying Zicam still don't know that they can buy stock in the company that sells it, and the best market conditions for short-selling have already come and gone. Give it up, Buckaroo.